Yasumoto H - Search Results

1

Current chemotherapeutic strategies against bladder cancer.

Mitsui Y, Yasumoto H, Arichi N, Honda S, Shiina H, Igawa M. Mitsui Y, et al. Among authors: yasumoto h. Int Urol Nephrol. 2012 Apr;44(2):431-41. doi: 10.1007/s11255-011-0009-8. Epub 2011 Jun 12. Int Urol Nephrol. 2012. PMID: 21667254 Review.

2

A case of testicular teratoma located in the opposite side of the upper abdominal wall.

Nakamoto T, Igawa M, Ueda M, Yasumoto H, Usui T. Nakamoto T, et al. Among authors: yasumoto h. Int J Urol. 1994 Jun;1(2):187-8. doi: 10.1111/j.1442-2042.1994.tb00034.x. Int J Urol. 1994. PMID: 7627858 Free article.

3

Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer.

Mutaguchi K, Yasumoto H, Mita K, Matsubara A, Shiina H, Igawa M, Dahiya R, Usui T. Mutaguchi K, et al. Among authors: yasumoto h. Cancer Res. 2003 Nov 15;63(22):7717-23. Cancer Res. 2003. PMID: 14633696

4

Lower urinary tract symptoms after radical perineal prostatectomy.

Matsubara A, Yoneda T, Yasumoto H, Teishima J, Shiina H, Igawa M, Mita K, Usui T. Matsubara A, et al. Among authors: yasumoto h. Jpn J Clin Oncol. 2007 Jul;37(7):534-9. doi: 10.1093/jjco/hym058. Epub 2007 Jul 24. Jpn J Clin Oncol. 2007. PMID: 17652108

5

Identification of lymphatic pathway involved in the spreading of prostate cancer by fluorescence navigation approach with intraoperatively injected indocyanine green.

Inoue S, Shiina H, Arichi N, Mitsui Y, Hiraoka T, Wake K, Sumura M, Honda S, Yasumoto H, Urakami S, Matsubara A, Igawa M. Inoue S, et al. Among authors: yasumoto h. Can Urol Assoc J. 2011 Aug;5(4):254-9. doi: 10.5489/cuaj.10159. Can Urol Assoc J. 2011. PMID: 21801682 Free PMC article.

6

A case of primary retroperitoneal serous adenocarcinoma.

Arichi N, Yasumoto H, Mitsui Y, Hiraoka T, Honda S, Shiina H, Igawa M. Arichi N, et al. Among authors: yasumoto h. Int J Urol. 2011 Dec;18(12):844-6. doi: 10.1111/j.1442-2042.2011.02875.x. Epub 2011 Oct 12. Int J Urol. 2011. PMID: 21992013

7

[A history and current state of chemotherapy against prostate cancer].

Yasumoto H, Igawa M. Yasumoto H, et al. Nihon Rinsho. 2011 Jun;69 Suppl 5:516-21. Nihon Rinsho. 2011. PMID: 22208036 Japanese. No abstract available.

8

[Essential effect of radical perineal prostatectomy on longitudinal alteration of QOL in patients with localized prostate cancer].

Shiina H, Yasumoto H, Igawa M, Inoue S. Shiina H, et al. Among authors: yasumoto h. Nihon Rinsho. 2011 Jun;69 Suppl 5:615-9. Nihon Rinsho. 2011. PMID: 22208054 Japanese. No abstract available.

9

Indocyanine green (ICG)-based fluorescence navigation system for discrimination of kidney cancer from normal parenchyma: application during partial nephrectomy.

Mitsui Y, Shiina H, Arichi N, Hiraoka T, Inoue S, Sumura M, Honda S, Yasumoto H, Igawa M. Mitsui Y, et al. Among authors: yasumoto h. Int Urol Nephrol. 2012 Jun;44(3):753-9. doi: 10.1007/s11255-011-0120-x. Epub 2012 Jan 4. Int Urol Nephrol. 2012. PMID: 22215306

10

Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery.

Mitsui Y, Shiina H, Hiraki M, Arichi N, Hiraoka T, Sumura M, Honda S, Yasumoto H, Igawa M. Mitsui Y, et al. Among authors: yasumoto h. Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):487-96. doi: 10.1158/1055-9965.EPI-11-0970. Epub 2012 Jan 13. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22246902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters